Role of raw materials in biopharmaceutical manufacturing: risk analysis and fingerprinting.

Accurate fingerprinting of critical raw materials that have significant impact on process performance and product quality is a necessary precursor for implementation of QbD in process and product development. This article presents a review of major developments in this space in the last 10 years, with a special emphasis on those in last 5 years. A step by step approach for managing raw materials in the QbD paradigm has been proposed. We think that it is necessary for the biotech industry to better manage variability originating from raw materials if holistic implementation of QbD is to be achieved.

[1]  A. Rathore,et al.  Application of Multivariate Data Analysis for Identification and Successful Resolution of a Root Cause for a Bioprocessing Application , 2008, Biotechnology progress.

[2]  S Vaidyanathan,et al.  Assessment of near-infrared spectral information for rapid monitoring of bioprocess quality. , 2001, Biotechnology and bioengineering.

[3]  Urs von Stockar,et al.  Real-time in situ monitoring of freely suspended and immobilized cell cultures based on mid-infrared spectroscopic measurements. , 2002, Biotechnology and bioengineering.

[4]  J. Menezes,et al.  Near‐infrared and two‐dimensional fluorescence spectroscopy monitoring of monoclonal antibody fermentation media quality: Aged media decreases cell growth , 2013, Biotechnology journal.

[5]  A S Rathore,et al.  Process analytical technology (PAT) for biopharmaceutical products , 2010, Analytical and bioanalytical chemistry.

[6]  Theodora Kourti,et al.  The Process Analytical Technology initiative and multivariate process analysis, monitoring and control , 2006, Analytical and bioanalytical chemistry.

[7]  Anurag S Rathore,et al.  Application of near‐infrared (NIR) spectroscopy for screening of raw materials used in the cell culture medium for the production of a recombinant therapeutic protein , 2009, Biotechnology progress.

[8]  J. Bones,et al.  Examining the sources of variability in cell culture media used for biopharmaceutical production , 2017, Biotechnology Letters.

[9]  J. K. Simonelli,et al.  Mapping and Identification of Biopharmaceutical Grade Cell Culture Media by MEKC , 2007 .

[10]  B. Kerwin.  Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. , 2008, Journal of pharmaceutical sciences.

[11]  Gianni Torraca,et al.  Nondestructive detection of glass vial inner surface morphology with differential interference contrast microscopy. , 2012, Journal of pharmaceutical sciences.

[12]  Brian McNeil,et al.  The potential of mid infrared spectroscopy (MIRS) for real time bioprocess monitoring. , 2006, Analytica chimica acta.

[13]  Erno Pungor,et al.  Proteomic Analysis for the Assessment of Different Lots of Fetal Bovine Serum as a Raw Material for Cell Culture. Part IV. Application of Proteomics to the Manufacture of Biological Drugs , 2008, Biotechnology progress.

[14]  Martin Rhiel,et al.  Nondestructive near‐infrared spectroscopic measurement of multiple analytes in undiluted samples of serum‐based cell culture media , 2002, Biotechnology and bioengineering.

[15]  David S. Wishart,et al.  Characterization of biopharmaceuticals by NMR spectroscopy , 2013 .

[16]  Jose C. Menezes,et al.  Predicting mab product yields from cultivation media components, using near‐infrared and 2D‐fluorescence spectroscopies , 2011, Biotechnology progress.

[17]  A. Rathore,et al.  Quality by design for biopharmaceuticals , 2009, Nature Biotechnology.

[18]  Pedro Carmona,et al.  Elucidation of structural changes in soy protein isolate upon heating by Raman spectroscopy , 2009 .

[19]  Wei Wang,et al.  Impact of residual impurities and contaminants on protein stability. , 2014, Journal of pharmaceutical sciences.

[20]  P. Højrup,et al.  Characterization of different cell culture media for expression of recombinant antibodies in mammalian cells: Presence of contaminating bovine antibodies. , 2005, Protein expression and purification.

[21]  Lilli Møller Andersen,et al.  Quality Risk Management , 2021, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.

[22]  A. Mantel‐Teeuwisse,et al.  Characteristics of product recalls of biopharmaceuticals and small-molecule drugs in the USA. , 2016, Drug discovery today.

[23]  Steven Kozlowski,et al.  Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. , 2009, Journal of pharmaceutical sciences.

[24]  Anurag S. Rathore,et al.  Quality by design for biopharmaceuticals : principles and case studies , 2009 .

[25]  Seongkyu Yoon,et al.  Characterization of mammalian cell culture raw materials by combining spectroscopy and chemometrics , 2017, Biotechnology progress.

[26]  Jinshu Qiu,et al.  Monitoring utilizations of amino acids and vitamins in culture media and Chinese hamster ovary cells by liquid chromatography tandem mass spectrometry. , 2016, Journal of pharmaceutical and biomedical analysis.

[27]  Alan G. Ryder,et al.  Rapid characterization and quality control of complex cell culture media solutions using raman spectroscopy and chemometrics , 2010, Biotechnology and bioengineering.

[28]  Sarfaraz K. Niazi.  GOOD Manufacturing Practice Guide for Active Pharmaceutical Ingredients , 2019 .

[29]  Seongkyu Yoon,et al.  Estimation of raw material performance in mammalian cell culture using near infrared spectra combined with chemometrics approaches , 2012, Biotechnology progress.

[30]  Seongkyu Yoon,et al.  Data fusion‐based assessment of raw materials in mammalian cell culture , 2012, Biotechnology and bioengineering.

[31]  Gary Rogers,et al.  Routine Screening for the Presence of Adulteration in Raw Materials Using Automated Nuclear Magnetic Resonance Spectroscopy , 2012, PDA Journal of Pharmaceutical Science and Technology.

[32]  M. Arora.  Cell Culture Media: A Review , 2013 .

[33]  Amine Kamen,et al.  Micro-quantitation of lipids in serum-free cell culture media: a critical aspect is the minimization of interference from medium components and chemical reagents. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[34]  Theodore W Randolph,et al.  Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution. , 2009, Journal of pharmaceutical sciences.

[35]  Alan G. Ryder,et al.  Prediction of cell culture media performance using fluorescence spectroscopy. , 2010, Analytical chemistry.

[36]  Zhuangrong Huang,et al.  Combined metabolomics and proteomics reveals hypoxia as a cause of lower productivity on scale-up to a 5000-liter CHO bioprocess. , 2016, Biotechnology journal.

[37]  Atsushi Hashimoto,et al.  Simple and rapid determination of metabolite content in plant cell culture medium using an FT-IR/ATR method , 2005, Bioprocess and biosystems engineering.

[38]  Anurag S Rathore,et al.  Design of experiments applications in bioprocessing: Concepts and approach , 2014, Biotechnology progress.

[39]  Tatsuma Yao,et al.  Animal‐cell culture media: History, characteristics, and current issues , 2017, Reproductive medicine and biology.

[40]  A J Morris,et al.  Enhanced bio-manufacturing through advanced multivariate statistical technologies. , 2002, Journal of biotechnology.

[41]  Zai-Qing Wen,et al.  Detection of Trace Melamine in Raw Materials Used for Protein Pharmaceutical Manufacturing Using Surface-Enhanced Raman Spectroscopy (SERS) with Gold Nanoparticles , 2011, Applied spectroscopy.

[42]  Yijia Jiang,et al.  Root Cause Analysis of Tungsten-Induced Protein Aggregation in Pre-filled Syringes. , 2010, PDA journal of pharmaceutical science and technology.

[43]  Theodore W Randolph,et al.  IgG particle formation during filling pump operation: a case study of heterogeneous nucleation on stainless steel nanoparticles. , 2009, Journal of pharmaceutical sciences.